Table 2.

Independent Predictors of Overall and CV Mortality in NAFLD, NHANES III (1988‐1994)

Covariate	Overall Mortality aHR (95% CI)	P	Cardiovascular Mortality aHR (95% CI)	P
Group by medication use		0.1512		0.409
No medication use	Reference		Reference
Statin use	0.95 (0.37‐2.44)	0.9143	1.20 (0.26‐5.54)	0.8092
Other LLA use	1.43 (0.99‐2.07)	0.0544	1.63 (0.70‐3.76)	0.2488
Age, years		< 0.0001		< 0.0001
20‐44	Reference		Reference
45‐54	2.74 (1.68‐4.48)	0.0001	2.81 (1.49‐5.29)	0.0019
55‐64	7.31 (4.92‐10.85)	< 0.0001	8.85 (3.61‐21.68)	< 0.0001
65‐74	15.58 (10.72‐22.63)	< 0.0001	21.49 (11.04‐41.84)	< 0.0001
Male	1.20 (0.99‐1.47)	0.0681	1.48 (0.86‐2.57)	0.1557
Race		0.0011		0.0882
non‐Hispanic white	Reference		Reference
non‐Hispanic black	1.11 (0.92‐1.35)	0.2700	0.93 (0.56‐1.56)	0.7863
Mexican American	0.91 (0.72‐1.16)	0.4368	0.85 (0.55‐1.32)	0.4691
Other	0.40 (0.25‐0.65)	0.0004	0.14 (0.03‐0.65)	0.0133
Active smoker	1.94 (1.48‐2.55)	< 0.0001	2.65 (1.76‐3.97)	< 0.0001
Obese	0.96 (0.77‐1.20)	0.7112	1.03 (0.64‐1.66)	0.9030
DM	1.79 (1.40‐2.30)	< 0.0001	1.89 (1.08‐3.30)	0.0260
HL	1.10 (0.84‐1.45)	0.4687	1.23 (0.78‐1.94)	0.3631
HTN	1.13 (0.84‐1.54)	0.4121	1.17 (0.75‐1.82)	0.4834
CKD	1.89 (1.48‐2.41)	< 0.0001	1.82 (0.92‐3.62)	0.0860
History of cancer	1.21 (0.87‐1.67)	0.2502	0.75 (0.45‐1.24)	0.2578
History of CVD	2.03 (1.57‐2.63)	< 0.0001	3.69 (2.23‐6.08)	< 0.0001